These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 32495720)
1. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice. Yokono Y; Hanada K; Narita M; Tatara Y; Kawamura Y; Miura N; Kitayama K; Nakata M; Nozaka M; Kato T; Kudo N; Tsushima M; Toyama Y; Itoh K; Tomita H J Am Heart Assoc; 2020 Jun; 9(12):e015616. PubMed ID: 32495720 [TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice. Narita M; Hanada K; Kawamura Y; Ichikawa H; Sakai S; Yokono Y; Senoo M; Narita N; Shimada M; Osanai T; Okumura K; Tomita H Hypertens Res; 2021 Oct; 44(10):1261-1273. PubMed ID: 34285375 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 1 inhibition by SCH79797 attenuates left ventricular remodeling and profibrotic activities of cardiac fibroblasts. Sonin DL; Wakatsuki T; Routhu KV; Harmann LM; Petersen M; Meyer J; Strande JL J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):460-75. PubMed ID: 23598708 [TBL] [Abstract][Full Text] [Related]
4. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice. Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112 [TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway. Ichikawa H; Shimada M; Narita M; Narita I; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H J Am Heart Assoc; 2019 Apr; 8(8):e012195. PubMed ID: 30957622 [TBL] [Abstract][Full Text] [Related]
6. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension. Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339 [TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling. Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674 [TBL] [Abstract][Full Text] [Related]
8. Alamandine improves cardiac remodeling induced by transverse aortic constriction in mice. Silva MM; de Souza-Neto FP; Jesus ICG; Gonçalves GK; Santuchi MC; Sanches BL; de Alcântara-Leonídio TC; Melo MB; Vieira MAR; Guatimosim S; Santos RAS; da Silva RF Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H352-H363. PubMed ID: 33124885 [TBL] [Abstract][Full Text] [Related]
10. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats. Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494 [TBL] [Abstract][Full Text] [Related]
11. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone. López-Andrés N; Martin-Fernandez B; Rossignol P; Zannad F; Lahera V; Fortuno MA; Cachofeiro V; Díez J Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2372-82. PubMed ID: 21926338 [TBL] [Abstract][Full Text] [Related]
12. Tumor Necrosis Factor - Alpha Is Essential for Angiotensin II-Induced Ventricular Remodeling: Role for Oxidative Stress. Sriramula S; Francis J PLoS One; 2015; 10(9):e0138372. PubMed ID: 26378790 [TBL] [Abstract][Full Text] [Related]
13. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats. Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575 [TBL] [Abstract][Full Text] [Related]
14. Xinmailong mitigated epirubicin-induced cardiotoxicity via inhibiting autophagy. Li H; Mao Y; Zhang Q; Han Q; Man Z; Zhang J; Wang X; Hu R; Zhang X; Irwin DM; Niu G; Tan H J Ethnopharmacol; 2016 Nov; 192():459-470. PubMed ID: 27586823 [TBL] [Abstract][Full Text] [Related]